US Stem Cell Market Analysis

Table of Contents

• 1. Analyst View
• 2. US Stem Cell Market Overview
  • 2.1 Understanding Stem Cell
  • 2.2 Stem Cell Market
• 3. Stem Cell Therapy Market Structure
  • 3.1 By Product
    • 3.1.1 Adult Stem Cell
    • 3.1.2 Embryonic Stem Cell
  • 3.2 By Technology
    • 3.2.1 Therapeutic Banking
    • 3.2.2 Cellular Therapeutics
• 4. Emerging Areas for Therapeutic Applications
  • 4.1 Spinal Cord Injury
  • 4.2 Biologicals and Associated Hardware
  • 4.3 Myocardial Infarction
  • 4.4 Limb Ischemia
• 5. Industry Trends
  • 5.1 Potential Patient Population
  • 5.2 Costly Treatments
  • 5.3 Rising Healthcare Spending
  • 5.4 Government Initiatives
  • 5.5 Unmet Medical Needs
  • 5.6 Stem Cell - An Emerging Therapy
  • 5.7 Regulatory Constraints and Political Interference
  • 5.8 Need for Universal Allogenic Treatments
• 6. Key Players
  • 6.1 Geron Corporation
  • 6.2 StemCells Inc.
  • 6.3 Advanced Cell Technology Inc
  • 6.4 Neuralstem Inc.
  • 6.5 Aastrom Biosciences Inc
  • 6.6 Thermogenesis Corp

List of Figures:

• Figure 2-1: Stem Cell Therapy Development Process
• Figure 2-2: Stem Cell Market by Region (%), 2005
• Figure 2-3: Forecast for Stem Cell Market by Region (%), 2010
• Figure 2-4: Share in Global Cord Blood Bank Market (2007)
• Figure 2-5: Cord Blood Bank by Region (%), 2005
• Figure 3-1: Stem Cell Therapy Market (Million US$), 2005-2008
• Figure 3-2: Forecast for Stem Cell Therapy Market (Million US$), 2009-2012
• Figure 3-3: Stem Cell Product Sales (Million US$), 2006-2008
• Figure 3-4: Forecast for Stem Cell Product Sales (Million US$), 2009-2012
• Figure 3-5: Adult Stem Cell Product Market (Million US$), 2007 & 2009
• Figure 3-6: Cord Blood Bank Market (Million US$), 2007 & 2010
• Figure 3-7: Cord Blood Inventory in Public and Private Banks (Million), H1 2008
• Figure 3-8: Cord Blood Inventory in Public Banks by Place (Million), H1 2008
• Figure 3-9: Therapeutic Banking Market (Million US$), 2005-2008
• Figure 3-10: Forecast for Therapeutic Banking Market (Million US$), 2009-2012
• Figure 3-11: Cellular Therapeutics Market (Million US$), 2005-2008
• Figure 3-12: Forecast for Cellular Therapeutic Market (Million US$), 2009-2012
• Figure 4-1: Patients Suffering from Spinal Cord Injury (Million), 2006, 2008 & 2009
• Figure 4-2: Patients Suffering from Myocardial Infarction (Million), 2006 & 2008
• Figure 5-1: Per Head Healthcare Spending (US$), 2005-2008
• Figure 5-2: Leading Causes of Death (Numbers)

List of Tables:

• Table 4-1: Stem Cell Therapy Market Potential in Spinal Cord Injury (2009)
• Table 5-1: Potential Patient Population for Stem Cell Therapy (Million), 2005
• Table 5-2: Annual Direct Expenditures for Selected Diseases (Billion US$), 2005
• Table 5-3: Stem Cell Therapy Cost Comparison to Leading Treatment (Million US$)